共 50 条
Impact of Diabetes Mellitus on Percutaneous Coronary Intervention in Chinese Patients: A Large Single-Center Data
被引:12
|作者:
Wang, Huanhuan
[1
]
Gao, Zhan
[1
]
Song, Ying
[1
]
Tang, Xiaofang
[1
]
Xu, Jingjing
[1
]
Jiang, Ping
[1
]
Jiang, Lin
[1
]
Chen, Jue
[1
]
Gao, Lijian
[1
]
Song, Lei
[1
]
Zhang, Yin
[1
]
Zhao, Xueyan
[1
]
Qiao, Shubin
[1
]
Yang, Yuejin
[1
]
Gao, Runlin
[1
]
Xu, Bo
[1
]
Yuan, Jinqing
[1
]
机构:
[1] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, A 167 Beilishi Rd, Beijing 100037, Peoples R China
来源:
基金:
中国国家自然科学基金;
关键词:
percutaneous coronary angioplasty;
drug-eluting stent;
diabetes mellitus;
ELUTING STENT;
RISK-FACTORS;
OUTCOMES;
DISEASE;
REVASCULARIZATION;
RESTENOSIS;
THROMBOSIS;
THERAPY;
D O I:
10.1177/0003319717735226
中图分类号:
R6 [外科学];
学科分类号:
1002 ;
100210 ;
摘要:
Aim: To investigate the impact of diabetic status on 2-year clinical outcomes in Chinese patients undergoing contemporary percutaneous coronary intervention (PCI) treatment. Methods and Results: A total of 10 724 consecutive patients underwent PCI at Fu Wai Hospital were prospectively collected. Two-year clinical outcomes were compared between patients with and without diabetes mellitus (DM). Diabetic patients had more baseline clinical risks and more extensive coronary disease. During 2-year follow-up, the rates of all-cause death, myocardial infarction (MI), revascularization, and major adverse cardiac events (MACE) were significantly higher in DM group. After multivariable-adjusted Cox regression analysis, DM was an independent risk factor for MACE but not for the individual components of MACE. After performing propensity score matching, rates of all-cause death, MI, revascularization, stroke, stent thrombosis, and MACE were not significantly different between the 2 groups, and DM was not predictive of MACE and any clinical adverse outcomes. Conclusions: Diabetic patients who underwent PCI had worse prognosis including death and repeat revascularization during 2-year follow-up, but DM was not an independent risk factor for adverse clinical outcomes.
引用
收藏
页码:540 / 547
页数:8
相关论文